SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Sai Life Sciences informs about audited financial results

14 May 2025 Evaluate

Pursuant to Regulation 30, 33 and any other provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Sai Life Sciences has informed that, the Board of Directors of the Company, at its meeting held on Tuesday, 13 May 2025, considered and approved the following: 1. Audited Financial Results (Standalone and Consolidated) of the Company and noted the Audit Report of the Statutory Auditors, Deloitte Haskins & Sells LLP for the quarter and financial year ended 31 March 2025. A copy of the same are enclosed as Annexure. The Meeting of the Board of Directors was duly commenced at 6:30 pm (IST) and concluded at 10:30 pm (IST).

The above information is a part of company’s filings submitted to BSE.

Sai Life Sciences Share Price

1116.85 27.75 (2.55%)
08-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1847.30
Dr. Reddys Lab 1293.25
Cipla 1347.70
Zydus Lifesciences 938.90
Lupin 2377.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×